Primary cutaneous cryptococcosis: A distinct clinical entity

Clinical Infectious Diseases

Volumn 36, Issue 3, 2003, Pages 337-347

  Neuville, Ségolène ^e   Dromer, Françoise ^d   Morin, Odile ^b   Dupont, Bertrand ^a   Ronin, Olivier ^e   Lortholary, Olivier ^c   Bouchara, J P ^e   Chabasse, D ^e   Lecuit, A ^e   Aubin, F ^e   Bresson Vautrin, C ^e   Imbert, P ^e   Reboux, G ^e   Bertrand, A ^e   Dayan, A ^e   Jollivet, J P ^e   Bougnoux, M E ^e   Bazin, C ^e   Duhamel, C ^e   Dompmartin, A ^e   Boyer, P ^e   Allard, C ^e   Launay, L ^e   Mitteau, M ^e   Philippe, O ^e   Herve V ^e   Vaylet, F ^e   Devidas, A ^e   Malbrunot, C ^e   Matot, M E ^e   Bretagne, S ^e   Bournerias, I ^e   De Vregille, J ^e   Leblanc, A ^e   Chapiro, O ^e   Chevalier, J M ^e   Lafay, P ^e   Bosseray, A ^e   Lebeau, B ^e   Murat, C ^e   Bouteille, B ^e   Weinbreck, P ^e   Piens, M A ^e   Claudy, A ^e   Nguyen, A Michel ^e   Nezri, M ^e   Mourier, C ^e   Brocart, K ^e   Alzieu, P ^e   Hamidou, M ^e   Poirier, P ^e   Raffi, F ^e   Lachaud, L ^e   Pablo, M ^e   Kreis, H ^e   Kauffman Lacroix, C ^e   Jaussaud, R ^e   Toubas, D ^e   Belguise, J ^e   Gregory, A ^e   Prevot, O ^e   Liebeau, S ^e   Therizol Ferly, M ^e   Rosset, P ^e   Bourgoin, C ^e   Lheullier , J P ^e   more..

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b HÔTEL DIEU   (France)

^c AVICENNE HOSPITAL   (France)

^d INSTITUT PASTEUR   (France)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DERMATOMYCOSIS; FEMALE; FUNGUS ISOLATION; HUMAN; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; PHLEGMON; PRIORITY JOURNAL; REGISTER; REVIEW; SKIN INJURY;

ADULT; AGED; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DERMATOMYCOSES; FEMALE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0037310115     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/345956     Document Type: Review

References (104)

1. Powell KE, Dahl BA, Weeks RJ, Tosh FE. Airborne Cryptococcus neoformans: particles from pigeon excreta compatible with alveolar deposition. J Infect Dis 1972; 125:412-5.
2. Garcia-Hermoso D, Janbon G, Dromer F. Epidemiological evidence for dormant Cryptococcus neoformans infection. J Clin Microbiol 1999; 37:3204-9.
3. Goldman DL, Khine H, Abadi J, et al. Serologic evidence for Cryptococcus neoformans infection in early childhood. Pediatrics 2001; 107:E66.
4. Ansheng L, Nishimura K, Taguchi H, Tanaka R, Shaoxi W, Miyaji M. The isolation of Cryptococcus neoformans from pigeon droppings and serotyping of naturally and clinically sourced isolates in China. Mycopathologia 1993; 124:1-5.
5. Baro T, Torres-Rodriguez JM, Morera Y, Alia C, Lopez O, Mendez R. Serotyping of Cryptococcus neoformans from clinical and environmental sources in Spain. J Clin Microbiol 1999; 37:1170-2.
6. Garcia-Hermoso D, Mathoulin-Pélissier S, Couprie B, Ronin O, Dupont B, Dromer F. DNA typing suggests pigeon droppings as a source of pathogenic Cryptococcus neoformans serotype D. J Clin Microbiol 1997; 35:2683-5.
7. Halliday CL, Bui T, Krockenberger M, Malik R, Ellis DH, Carter DA. Presence of α and a mating types in environmental and clinical collections of Cryptococcus neoformans var. gattii strains from Australia. J Clin Microbiol 1999; 37:2920-6.
8. Kwon-Chung KJ, Bennett JE. Distribution of α and a mating types of Cryptococcus neoformans among natural and clinical isolates. Am J Epidemiol 1978; 108:337-40.
9. Lazera MS, Wanke B, Nihikawa NM. Isolation of both varieties of Cryptococcus neoformans from saprophytic sources in the city of Rio de Janeiro, Brazil. J Med Vet Mycol 1993; 31:449-54.
10. Ruiz A, Fromtling RA, Bulmer GS. Distribution of Cryptococcus neoformans in a natural site. Infect Immun 1981; 31:560-3.
11. Lazera MS, Pires FDA, Camillo-Coura L, et al. Natural habitat of Cryptococcus neoformans var. neoformans in decaying wood forming hollows in living trees. J Med Vet Mycol 1996; 34:127-31.
12. Lopez-Martinez R, Castañon-Olivarez LR. Isolation of Cryptococcus neoformans var. neoformans from bird droppings, fruits, and vegetables in Mexico City. Mycopathologia 1995; 129:25-8.
13. Swinne D, Kayembe K, Niyimi M. Isolation of saprophytic Cryptococcus neoformans var. neoformans in Kinshasa, Zaire. Ann Soc Belg Med Trop 1986; 66:57-61.
14. Bennett JE, Kwon-Chung KJ, Howard DH. Epidemiologic differences among serotypes of Cryptococcus neoformans. Am J Epidemiol 1977; 105:582-6.
15. Kwon-Chung KJ, Bennett JE. Epidemiologic differences between the two varieties of Cryptococcus neoformans. Am J Epidemiol 1984; 120:123-30.
16. Franzot SP, Salkin IF, Casadevall A. Cryptococcus neoformans var. grubii: separate varietal status for Cryptococcus neoformans serotype A isolates. J Clin Microbiol 1999; 37:838-40.
17. Randhawa HS, Paliwal DK. Occurrence and significance of Cryptococcus neoformans in the oropharynx and on the skin of a healthy population. J Clin Microbiol 1977; 6:325-7.
18. Kwon-Chung KJ, Bennett JE. Cryptococcosis. In: Kwon-Chung KJ, Bennett JE, eds. Medical mycology. Philadelphia: Lea & Febiger, 1992:397-446.
19. Diamond RD, Bennett JE. Prognostic factors in cryptococcal meningitis: a study in 111 cases. Ann Intern Med 1974; 80:176-81.
20. Dromer F, Mathoulin S, Dupont B, Brugière O, Letenneur L. Comparison of amphotericin B and fluconazole efficacy in the treatment of cryptococcosis in HIV-negative patients: retrospective analysis of 83 cases. French Cryptococcosis Study Group. Clin Infect Dis 1996; 22(Suppl 2):S154-60.
21. Lewis JL, Rabinovich S. The wide spectrum of cryptococcal infections. Am J Med 1972; 53:315-22.
22. Pappas PG, Perfect JR, Cloud GA, et al. Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis 2001; 33:690-9.
23. Singh N, Gayowski T, Wagener MM, Marino IR. Clinical spectrum of invasive cryptococcosis in liver transplant recipients receiving tacrolimus. Clin Transplant 1997; 11:66-70.
24. Dromer F, Mathoulin S, Dupont B, Letenneur L, Ronin O. Individual and environmental factors associated with Cryptococcus neoformans serotype D infections in France. French Cryptococcosis Study Group. Clin Infect Dis 1996; 23:91-6.
25. Casadevall A, Mukherjee J, Yuan R, Perfect J. Management of injuries caused by Cryptococcus neoformans-contaminated needles. Clin Infect Dis 1994; 19:951-3.
26. Dromer F, Mathoulin S, Dupont B, Laporte A. Epidemiology of cryptococcosis in France: 9-year survey (1985-1993). French Cryptococcosis Study Group. Clin Infect Dis 1996; 23:82-90.
27. Dromer F, Guého E, Ronin O, Dupont B. Serotyping of Cryptococcus neoformans by using a monoclonal antibody specific for capsular polysaccharide. J Clin Microbiol 1993; 31:359-63.
28. Abdel-Fatah A, Abu Zid MS, Ghaly AF. Primary cutaneous cryptococcosis in Egypt. Int J Dermatol 1975; 14:606-9.
29. Anthony SA, Antony SJ. Primary cutaneous Cryptococcus in non-immunocompromised patients. Cutis 1995; 56:96-8.
30. Azulay RD, Muri Mendonça IR, Marcia Santos C, et al. Cutaneous cryptococcosis associated with lepromatous leprosy. Int J Dermatol 2001; 40:412-4.
31. Baes H, Van Cutsem J. Primary cutaneous cryptococcosis. Dermatologica 1985; 171:357-61.
32. Bee OB, Tan T, Pang R. A case of primary cutaneous cryptococcosis successfully treated with miconazole. Arch Dermatol 1981; 117:290-1.
33. Bellosta M, Gaviglio MR, Mosconi M, Cavanna C, Viglio A, Rabbiosi G. Primary cutaneous cryptococcosis in an HIV-negative patient. Eur J Dermatol 1999; 9:224-6.
34. Blanc C, Bazex J. Un cas de cryptococcose cutanée primitive chez un sujet sain. Ann Dermatol Venereol 1979; 106:807-11.
35. Bohne T, Sander A, Pfister-Wartha A, Schöp E. Primary cutaneous cryptococcosis following trauma of the right forearm. Mycoses 1996; 39:457-9.
36. Butler WP, Kaufer GI. Primary cutaneous cryptococcosis successfully treated with outpatient amphotericin B and 5-fluorocytosine. NITA 1985; 8:295-7.
37. Difonzo EM, Palleschi GM, Vannini P, Panconesi E. Therapeutic experience with ketoconazole. Drugs Exp Clin Res 1986; 12:397-403.
38. Dounis E, Giamarellou H, Peppas T, Sfikakis P. Skull, patella, and thigh cryptococcosis after a crashing injury of the temporal bone. J Chemother 1991; 3:130-3.
39. Erdem G, Connelly BL. Isolated cutaneous cryptococcosis in an otherwise healthy girl. Pediatr Infect Dis J 2000; 19:85-6.
40. Feldman SR, Fleischer AB, Resnick SD. Fluconazole treatment of cutaneous cryptococcosis. Arch Dermatol 1992; 128:1045-6.
41. Gatti M, Di Silverio A, Cespa M, Mosca M. Primary unusual cutaneous cryptococcosis in an HIV former drug-abuser patient. Mycoses 1997; 40:101-2.
42. Geyer SJ, Werber JC. Localized cutaneous cryptococcosis in an immunosuppressed man. Int J Dermatol 1984; 23:673-5.
43. Goh CL. Cutaneous cryptococcosis successfully treated with itraconazole. Cutis 1993; 51:377-80.
44. Goonetilleke AKE, Krause K, Slater DN, Dev D, Wood ML, Basran GS. Primary cutaneous cryptococcosis in an immunocompromised pigeon keeper. Br J Dermatol 1995; 133:650-2.
45. Gordon PM, Ormerod AD, Harvey G, Atkinson P, Best PV. Cutaneous cryptococcal infection without immunodeficiency. Clin Exp Dermatol 1994; 19:181-4.
46. Granier F, Kanitakis J, Hermier C, Zhu YY, Thivolet J. Localized cutaneous cryptococcosis successfully treated with ketoconazole. J Am Acad Dermatol 1987; 16:243-9.
47. Hamann ID, Gillepsie RJ, Ferguson JK. Primary cryptococcal cellulitis caused by Cryptococcus neoformans var. gattii in an immunocompetent host. Australas J Dermatol 1997; 38:29-32.
48. Handa S, Nagaraja, Chakraborty A, Kumar B. Primary cutaneous cryptococcosis in an immune competent patient. J Eur Acad Dermatol Venereol 1998; 10:167-9.
49. Hurwich BJ, Domonkos AN. Primary cutaneous cryptococcosis: seroimmunologic and fluorescent antibody studies. N Y State J Med 1970; 70:1075-9.
50. Hunger RE, Paredas BE, Quattroppani C, Krähenbühl S, Braathen LR. Primary cutaneous cryptococcosis in a patient with systemic immunosuppression after liver transplantation. Dermatology 2000; 200: 352-5.
51. Iacobellis W, Jacobs MI, Cohen RP. Primary cutaneous cryptococcosis. Arch Dermatol 1979; 115:984-5.
52. Kimura M, Kadota E, Satou T, Yoneda E, Furuta T. Case report: cryptococcal cellulitis showing necrotizing vasculitis. Mycoses 2001; 44:115-8.
53. Micalizzi C, Persi A, Parodi A. Primary cutaneous cryptococcosis in an immunocompetent pigeon keeper. Clin Exp Dermatol 1997; 22:195-7.
54. Miura T, Akiba H, Saito N, Seiji M. Primary cutaneous cryptococcosis. Dermatologica 1971; 142:374-9.
55. Moreno C, Taddeucci P, Donati D, Miracco C, Massai L. Primary cutaneous cryptococcosis due to Cryptococcus neoformans in a woman with non-Hodgkin's lymphoma. Acta Derm Venereol 2001; 81:220-1.
56. Moreno Castillo JL, Del Negro G, Heins-Vaccari E, Takahashi de Melo N. Primary cutaneous cryptococcosis. Mycopathologia 1986; 96:25-8.
57. Moriame-Roussel N, de Dobbeleer G, Mindlin A, Song M. Un cas de cryptococcose cutanée primitive. Arch Belg Dermatol 1974; 30:275-7.
58. Naka W, Masuda M, Konohana A, Shinoda T, Nishikawa T. Primary cutaneous cryptococcosis and Cryptococcus neoformans serotype D. Clin Exp Dermatol 1995; 20:221-5.
59. Ng WF, Loo KT. Cutaneous cryptococcosis - primary versus secondary disease: report of two cases and review of the literature. Am J Dermatopathol 1993; 15:372-7.
60. Nicolas C, Truchetet F, Christian B, Dorvaux V, Cuny JF. Ulcération étendue du cuir chevelu révélant une cryptococcose chez un malade VIH positif. Ann Dermatol Venereol 2000; 127:188-90.
61. Noble RC, Fajardo LF. Primary cutaneous cryptococcosis. Am J Clin Pathol 1972; 57:13-22.
62. Patel P, Ramanathan J, Kayser M, Baran J. Primary cutaneous cryptococcosis of the nose in an immunocompetent woman. J Am Acad Dermatol 2000; 43:344-5.
63. Rao TV, Rao KS, Satyanarayana CV. Primary cutaneous cryptococcal granuloma in a child. J Pediatr Surg 1976; 11:267-8.
64. Salm R, Groth D, Kappe R, Müller J. Primary cutaneous cryptococcosis after microtrauma of the right index finger. Mycoses 1988; 31(Suppl 1):S88-92.
65. Sato T, Koseki S, Takahashi S, Maie O. Localized cutaneous cryptococcosis successfully treated with itraconazole: review of medication in 18 cases in Japan. Mycoses 1990; 33:455-63.
66. Song IC, Hunter JG. Primary cutaneous cryptococcosis as the presenting manifestation of AIDS. Plast Reconstr Surg 1992; 90:1065-7.
67. Sussman EJ, McMahon F, Wright D, Friedman HM. Cutaneous cryptococcosis without evidence of systemic involvement. J Am Acad Dermatol 1984; 11:371-4.
68. Vandersmissen G, Meuleman L, Tits G, Verhaeghe A, Peetermans WE. Cutaneous cryptococcosis in corticosteroid-treated patients without AIDS. Acta Clin Belg 1996; 51:111-7.
69. Vogelaers D, Petrovic M, Deroo M, et al. A case of primary cutaneous cryptococcosis. Eur J Clin Microbiol Infect Dis 1997; 16:150-2.
70. Webling DD, Mahajani A. Localized dermal cryptococcosis following scorpion sting. Australas J Dermatol 1981; 22:127-8.
71. Cusini M, Cagliani P, Grimalt R, Tadini G, Alessi E. Primary cutaneous cryptococcosis in a patient with the acquired immunodeficiency syndrome. Arch Dermatol 1991; 127:1848-9.
72. Yu RY. Cutaneous cryptococcosis. Mycoses 1996; 39:207-10.
73. Grégory A, Meillet D, Salem M, Prévost O. Cryptococcose cutanée primitive. Feuillets de Biologie 1999; 40:69-72.
74. Lacroix C, Gandon P, Lacroix P, Cazenave-Roblot F, Jacquemin JL. Cryptococcose cutanée primaire traitée par fluconazole. J Mycol Med 1993; 3:118-20.
75. Quéreux G, Milpied B, Morin O, et al. Cryptococcoses cutanées primitives chez des sujets séronégatifs pour le VIH. Ann Dermatol Venereol 2001; 128:1009-13.
76. Verneuil L, Dompmartin A, Duhamel C, et al. Panaris cryptococcique chez un malade VIH positif. Ann Dermatol Venereol 1995; 122:688-91.
77. Wilson JW. Cutaneous (chancriform) syndrome in deep mycoses. Arch Dermatol 1963; 87:121-5.
78. Glaser JB, Garden A. Inoculation of cryptococcosis without transmission of the acquired immunodeficiency syndrome. N Engl J Med 1985; 313:266.
79. Hay RJ. Cryptococcus neoformans and cutaneous cryptococcosis. Semin Dermatol 1985; 4:252-9.
80. Perfect JR, Seaworth BA. Penile cryptococcosis with review of mycotic infections of penis. Urology, 1985; 25:528-31.
81. Murakawa GJ, Kerschmann R, Berger T. Cutaneous Cryptococcus infection and AIDS: report of 12 cases and review of the literature. Arch Dermatol 1996; 132:545-8.
82. Pema K, Diaz J, Guerra LG, Nabhan D, Verghese A. Disseminated cryptococcosis: comparison of clinical manifestations in the pre-AIDS and AIDS era. Arch Intern Med 1994; 154:1032-4.
83. Cockerell CJ. Human immunodeficiency virus infection and the skin: a crucial interface. Arch Intern Med 1991; 151:1295-303.
84. Anderson DJ, Schmidt C, Goodman J, Pomeroy C. Cryptococcal disease presenting as cellulitis. Clin Infect Dis 1992; 14:666-72.
85. Massa MC, Doyle JA. Cutaneous cryptococcosis simulating pyoderma gangrenosum. J Am Acad Dermatol 1981; 5:32-6.
86. Crounse RG, Lerner AB. Cryptococcosis. AMA Arch Dermatol 1958; 77:210-5.
87. Rook A, Woods B. Cutaneous cryptococcosis. Br J Dermatol 1962; 74:43-9.
88. Wolfson JS, Sober AJ, Rubin RH. Dematologic manifestations of infections in immunocompromised patients. Medicine (Baltimore) 1985; 64:115-33.
89. Chu AC, Hay RJ, McDonald DM. Cutaneous cryptococcosis. Br J Dermatol 1980; 103:95-100.
90. Sarosi GA, Silberfarb PM, Tosh FE. Cutaneous cryptococcosis: a sentinel of disseminated disease. Arch Dermatol 1971; 104:1-3.
91. Feldmesser M, Harris C, Reichberg S, Khan S, Casadevall A. Serum cryptococcal antigen in patients with AIDS. Clin Infect Dis 1996; 23:827-30.
92. Manfredi R, Maroni A, Mazzoni A, et al. Isolated detection of cryptococcal polysaccharide antigen in cerebrospinal fluid samples from patients with AIDS. Clin Infect Dis 1996; 23:849-50.
93. Temstet A, Roux P, Poirot JL, Ronin O, Dromer F. Evaluation of a monoclonal antibody-based latex agglutination test for diagnosis of cryptococcosis: comparison with two tests using polyclonal antibodies. J Clin Microbiol 1992; 30:2544-50.
94. Diamond RD, Bennett JE. Disseminated cryptococcosis in man: decreased lymphocyte transformation in response to Cryptococcus neoformans. J Infect Dis 1973; 127:694-7.
95. Vecchiarelli A. Immunoregulation by capsular components of Cryptococcus neoformans. Med Mycol 2000; 38:407-17.
96. Saag MS, Graybill RJ, Larsen RA, et al. Practice guidelines for the management of cryptococcal disease. Clin Infect Dis 2000; 30:710-8.
97. Lee SC, Dickson DW, Casadevall A. Pathology of cryptococcal meningoencephalitis: analysis of 27 patients with pathogenetic implications. Hum Pathol 1996; 27:839-47.
98. Lortholary O, Improvisi L, Rayhane N, et al. Cytokine profiles of AIDS patients are similar to those of mice with disseminated Cryptococcus neoformans infection. Infect Immun 1999; 67:6314-20.
99. Chrétien F, Lortholary O, Kansau I, Neuville S, Gray F, Dromer F. Pathogenesis of cerebral Cryptococcus neoformans infection after fungemia. J Infect Dis 2002; 186:522-30.
100. Lortholary O, Dromer F, Launay O, et al. Cytokine profiles in bronchoalveolar lavage fluid and blood in HIV-infected patients with Cryptococcus neoformans pneumonia [abstract 128]. In: Program and abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago). Washington, DC: American Society for Microbiology, 2001.
101. Hironaga M, Ikeda R, Fukazawa Y, Watanabe S. Mating types and serotypes of Cryptococcus neoformans isolated in Japan. Sabouraudia 1983; 21:73-8.
102. Rozenbaum R, Gonçalves AJR, Wanke B, et al. Cryptococcus neoformans varieties as agents of cryptococcosis in Brazil. Mycopathologia 1992; 119:133-6.
103. Tortorano AM, Viviani MA, Rigoni AL, Cogliati M, Roverselli A, Pagano A. Prevalence of serotype D in Cryptococcus neoformans isolates from HIV positive and HIV negative patients in Italy. Mycoses 1997; 40:297-302.
104. Martinez LR, Garcia-Rivera J, Casadevall A. Cryptococcus neoformans var. neoformans (serotype D) strains are more susceptible to heat than C. neoformans var. grubii (serotype A) strains. J Clin Microbiol 2001; 39:3365-7.